Top 10 Medical Equipment Trends in 2009

Top 10 Medical Equipment Trends in 2009

Top 10 Medical Equipment Trends in 2009

Summary

Global Markets Direct’s “Top 10 Medical Equipment Trends in 2009” report an essential source of information and analysis that will help answer questions like: which companies are poised for high growth in the coming few years?, which are the growth sectors?, how are competitors responding to changing market dynamics?, what products are in pipeline and how would they impact sector growth?, which medical equipment sectors would retain investor confidence?, and what are the regulatory trends in leading economies and emerging economies? These are among the many questions that will be answered with insightful analysis in this report. The report analyses the ten major trends expected to influence the future of global medical equipment industry.
A strong understanding of the key trends to impact the medical equipment industry will prove to be a decisive factor in strategic planning and decision making for all involved in the value chain - investors, manufacturers, distributors, regulators, payer/providers and analysts tracking this industry.

Scope

• The report covers information and analysis on medical equipment markets in North America, Europe, Asia Pacific, South Central America, Middle East and Africa.
• The report provides market size data and information on 10 medical equipment markets namely Cardiovascular devices, Orthopedic devices, Diagnostic Imaging, Anesthesia and respiratory devices, Drug delivery devices, ENT devices, Healthcare IT, Hospital supplies, In-vitro diagnostics and Diabetes care devices.
• Annualized market revenues data from 2000 to 2007, forecast forward for 5 years to 2012.
• Analysis and review of the key events and milestones that will impact the future of medical equipment market globally. Each trend independently researched to provide qualitative analysis of • what the implications on sectors are, and how are companies responding to these trends.
• Insightful review of key industry drivers, restraints and challenges which are likely to impact the global medical equipment industry in the long run.
• In-depth analysis of the medical equipment M&A landscape with a strong emphasis on the market players, likely to remain active in the near future.
• Key topics covered include the emergence of Direct to Consumer (DTC) marketing, increasing use of home and self care medical devices, the likely impact of the ongoing credit crunch and the expected landscape post the US presidential elections.
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct’s team of industry experts.

Reasons to buy

• Develop business strategies by understanding the trends shaping and driving the global medical equipment industry.
• Organize your sales and marketing efforts by identifying the prevalent and expected competitive landscape in different medical equipment markets.
• Design and develop more effective product development, marketing and sales strategies.
• Identify key players who are best positioned to take advantage of the emerging market opportunities.
• Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
• What’s the next being thing in the medical equipment technology landscape? – Identify, understand and capitalize.
• Do better by understanding the regulatory scenario in the leading economies. evaluate approval process and reimbursement trends to make your expansion plans more efficient, effective and timely.

1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What is this Report About? 12
2.2 Global Markets Direct Report Coverage 12
2.3 Definitions 13
2.3.1 Anesthesia and Respiratory Devices 13
2.3.2 Cardiovascular Devices 13
2.3.3 Dental Devices 13
2.3.4 Diabetes Care Devices 13
2.3.5 Diagnostic Imaging 13
2.3.6 Drug Delivery Devices 13
2.3.7 Endoscopy Devices 13
2.3.8 ENT Devices 14
2.3.9 Healthcare IT 14
2.3.10 Hospital Supplies 14
2.3.11 In Vitro Diagnostics 14
2.3.12 Nephrology and Urology Devices 14
2.3.13 Neurology Devices 14
2.3.14 Ophthalmic Devices 15
2.3.15 Orthopedic Devices 15
2.3.16 Patient Monitoring 15
2.3.17 Surgical Equipment 15
2.3.18 Wound Care Management 15
3 Top 10 Medical Equipment Trends in 2009 16
3.1 Executive Summary 17
4 Direct-to-consumer Advertising: Increased adoption to heat the market space 18
4.1 Overview 18
4.2 The FDA and the US Senate Special Committee on Aging 19
4.3 Reasons Companies are adopting DTC Advertising as a marketing strategy 20
4.4 DTC Advertising in the Cardiovascular Devices Market 20
4.5 DTC Advertising in the Orthopaedic Devices Market 21
4.6 DTC Advertising in Optometry 23
4.7 Future Outlook 23
5 Emerging Medical Device Technology Economies 24
5.1 Overview 24
5.2 Medical Device Technology in China 25
5.2.1 Regulatory Landscape 27
5.2.2 Operational Issues 27
5.3 Medical Device Technology in Russian Federation 27
5.3.1 Regulatory Landscape 29
5.3.2 Operational Issues 29
5.4 Medical Device Technology in Brazil 30
5.4.1 Regulatory Landscape 31
5.4.2 Operational Issues 32
5.5 Medical Device Technology in India 32
5.5.1 Regulatory Landscape 34
5.5.2 Operational Issues 34
5.6 Medical Device Technology in Taiwan 35
5.6.1 Regulatory Landscape 36
5.6.2 Operational Issues 37
5.7 Medical Device Technology in Republic of Korea 37
5.7.1 Regulatory Landscape 39
5.7.2 Operational Issues 39
5.8 Medical Tourism 40
5.8.1 Medical Tourism in India 41
6 Healthcare IT: Redefining the healthcare delivery and management 43
6.1 Overview 43
6.2 Impact of Healthcare IT 46
6.3 Healthcare Interoperability 46
6.4 Telehealth 47
6.4.1 PACS in Telehealth 47
6.4.2 Hospital Information Systems in Telehealth 49
6.5 Future Outlook 51
7 Drug eluting stents: Renewed flow in the US market 54
7.1 Overview 54
7.2 Is Drug Eluting Stent Safe? 55
7.2.1 HORIZONS AMI Trial 56
7.2.2 Medtronic's Third-Generation Endeavor Resolute 56
7.2.3 Abbott Laboratories SPIRIT I, II, III 56
7.3 Companies to Benefit 56
7.3.1 Boston Scientific 58
7.3.2 Abbott Laboratories 59
7.3.3 Medtronic 59
7.4 Future Outlook 59
8 The US hip resurfacing market: Over-hyped or else? 60
8.1 Overview 60
8.2 Reasons for Smith & Nephew’s Dominance 61
8.3 The US Hip Resurfacing Market Restraints 61
8.4 Conclusions 62
9 The Global Home Healthcare Equipment Market: Poised for robust return 63
9.1 Overview 63
9.2 Diabetes Care Devices 64
9.3 ENT Devices – Hearing Aids 67
9.4 Respiratory Devices 69
9.4.1 Continuous Positive Airway Pressure Devices (CPAP) and Nebulizers 70
9.5 Drug Delivery Devices 72
9.5.1 Inhalation Systems 73
9.5.2 Needle Free Injections 74
9.5.3 Infusion Pumps 75
9.6 Future Outlook 76
9.6.1 Wireless Technology 77
10 Companies to watch out for in 2009 78
10.1 Overview 78
10.2 Abbott Laboratories 78
10.2.1 Abbott Vascular 78
10.2.2 Abbott Diagnostics 79
10.2.3 Abbott Diabetes Care 80
10.3 Medtronic Corporation 80
10.3.1 Medtronic - Spinal Market 81
10.3.2 Medtronic - Cardiovascular (includes Cardiac Rhythm Management) 83
10.3.3 Medtronic – Biologics and Neurology Devices 85
10.3.4 Medtronic Diabetes Care – Third generation Guardian continuous glucose monitoring system 85
10.4 Hologic Corporation 87
10.4.1 Breast Tomosynthesis 88
10.5 Small Bone Innovations 90
10.6 Getinge AB 91
10.7 Integra 92
10.8 Edward Lifesciences Corporation 93
10.9 Core Essence Orthopedics Inc (Core) 94
10.10 Alcon - AcrySof ReSTOR Toric IOL 96
10.11 Volcano Corporation – IVUS Guided Balloon Catheter 97
10.12 AcuFocus Inc – AcuFocus ACI 7000 97
11 Wall Street financial crisis: What’s in store for the medical equipment industry? 99
11.1 A Backgrounder 99
11.2 The Medical Equipment Industry Perspective 100
11.3 Global Medical Equipment Deal Landscape 101
11.4 Impact Analysis 102
11.4.1 Montagu Private Equity terminates the sale of BSN Medical 104
11.4.2 Boston Scientific Corporation’s founders unload stock 104
11.4.3 Roche to acquire Genentech 105
11.5 Future Outlook 106
12 Barack Obama as the US President: Medical Equipment Industry perspective 108
12.1 Introduction 108
12.2 Issues in front of the US Healthcare System 108
12.3 Impact of Rising Healthcare costs 111
12.4 Barack Obama’s Healthcare Reforms Plan 112
12.4.1 Implications of Barack Obama’s Plan 113
12.4.2 Drawbacks of Barack Obama’s Plan 113
12.5 Medical Equipment Industry future in Barack Obama’s reign 113
13 Medical Equipment M&A Landscape for 2009 115
13.1 Overview 115
13.2 Acquisitions 118
13.2.1 Medtronic to acquire CryoCath Technologies: A move to strengthen stake in the atrial fibrillation market 120
13.2.2 Getinge to acquire Datascope: Another Cardiovascular leader in making 122
13.2.3 Zimmer Holdings to acquire Abbott Spine: A move to fortify the spine portfolio 124
13.2.4 GE Healthcare acquires Vital signs: A move to consolidate the anesthesia and respiratory product portfolio 124
13.3 Future Outlook 125
14 Appendix 126
14.1 Methodology 126
14.2 Coverage 126
14.3 Secondary Research 127
14.4 Primary Research 127
14.5 Models 128
14.6 Forecasts 128
14.7 Expert Panels 128
14.8 Contact Us 129
14.9 Disclaimer 129



1.1 List of Tables
Table 1: Major DTC Advertising Campaigns 18
Table 2: Orthopedic Devices , US, Overall Revenue ($ mn), 2000 – 2012 22
Table 3: Medical Equipment, China, Overall Revenue ($ mn), 2000 – 2012 26
Table 4: Medical Equipment, Russian Federation, Overall Revenue ($ mn), 2000-2012 28
Table 5: Medical Equipment, Brazil, Overall Revenue ($ mn), 2000 – 2012 31
Table 6: Medical Equipment, India, Overall Revenue ($ mn), 2000 – 2012 33
Table 7: Medical Equipment, Taiwan, Overall Revenue ($ mn), 2000-2012 36
Table 8: Medical Equipment, Republic of Korea, Overall Revenue ($ mn), 2000 – 2012 38
Table 9: Procedure costs , US, UK, India, Thailand, Singapore, ($), 2008 40
Table 10: Medical Tourism, India, Overall Revenue ($ mn), 2000 – 2012 42
Table 11: Healthcare IT, Global, Overall Revenue ($ mn), 2000 – 2012 44
Table 12: Healthcare IT, Revenue Breakup by Geography ($mn), 2007 45
Table 13: PACS, Global, Overall Revenue ($ mn), 2000 – 2012 48
Table 14: Hospital Information Systems, Global, Overall Revenue ($ mn), 2000 – 2012 50
Table 15: Healthcare IT, India, Overall Revenue ($ mn), 2000 – 2012 52
Table 16: Coronary Stent, US, Overall Revenue ($ mn), 2000 – 2007 55
Table 17: Drug Eluting Stent, US, Overall Revenue ($ mn), 2007 – 2012 57
Table 18: Hip Resurfacing, US, Overall Revenue ($ mn), 2006 – 2012 62
Table 19: Home Healthcare Equipment, Global, Overall Revenue ($ mn), 2007 – 2012 64
Table 20: Diabetes care devices, Global, Overall Revenue ($ mn), 2000 – 2012 65
Table 21: Glucose Monitoring and Insulin Delivery devices, Global, Overall Revenue ($ mn), 2000-2012 66
Table 22: Digital Signal Processing Hearing Aids, Global, Overall Revenue ($ mn), 2000 - 2012 68
Table 23: CPAP and Nebulizers, Global, Overall Revenue ($ mn), 2000 – 2012 71
Table 24: Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000 – 2012 72
Table 25: Dry Powdered Inhalers, Global, Overall Revenue ($ mn), 2000 – 2012 73
Table 26: Needle Free Injections, Global, Overall Revenue ($ mn), 2007-2012 75
Table 27: Infusion Pumps, Global, Overall Revenue ($ mn), 2000 – 2012 76
Table 28: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2007-2012 80
Table 29: Spinal Surgery, Global, Overall Revenue ($ mn), 2007-2012 82
Table 30: Spinal non-fusion, US, Overall Revenue ($ mn), 2007 – 2012 83
Table 31: Aortic Stent Graft, US, Overall Revenue ($ mn), 2000-2012 85
Table 32: Glucose Monitoring, US, Overall Revenue ($ mn), 2000 – 2012 87
Table 33: Full Field Digital Mammography, Global, Overall Revenue ($ mn), 2000 – 2012 90
Table 34: Hospital Supplies, Global, Overall Revenue ($ mn), 2000 – 2012 92
Table 35: Arthroscopy, US, Overall Revenue ($ mn), 2000 – 2012 95
Table 36: Intra Ocular Lens , US, Overall Revenue ($ mn), 2000 – 2012 97
Table 37: Soft Contact Lens, US, Overall Revenue ($ mn), 2000 – 2012 98
Table 38: The US National Health Expenditures, 2006 ($ bn) 110
Table 39: Number of persons without health insurance, US, 1997 – March, 2008 111
Table 40: Medical Equipment Financial Deals, January 1, 2008 – November 5. 2008 116
Table 41: Medical Equipment Financial Deals, by Market, January 1, 2008 – November 5. 2008 118
Table 42: Medical Equipment Acquisitions, by Market, January 1, 2008 – November 5. 2008 119



1.2 List of Figures
Figure 1: Cardiovascular, US, Diseases %, 2007 21
Figure 2: Orthopedic Devices , US, Overall Revenue ($ mn), 2000 – 2012 22
Figure 3: Medical Equipment, China, Overall Revenue ($ mn), 2000 – 2012 26
Figure 4: Medical Equipment, Russian Federation, Overall Revenue ($ mn), 2000-2012 28
Figure 5: Medical Equipment, Brazil, Overall Revenue ($ mn), 2000 – 2012 30
Figure 6: Medical Equipment, India, Overall Revenue ($ mn), 2000 – 2012 33
Figure 7: Medical Equipment, Taiwan, Overall Revenue ($ mn), 2000 – 2012 36
Figure 8: Medical Equipment, Republic of Korea, Overall Revenue ($ mn), 2000 – 2012 38
Figure 9: Medical Tourism, India, Overall Revenue ($ mn), 2002 – 2012 41
Figure 10: Healthcare IT, Global, Overall Revenue ($ mn), 2000 – 2012 44
Figure 11: Healthcare IT, Revenue Breakup by Geography (%), 2007 45
Figure 12: PACS, Global, Overall Revenue ($ mn), 2000 – 2012 48
Figure 13: PACS, Global, Company Share (%), 2007 49
Figure 14: Hospital Information Systems, Global, Overall Revenue ($ mn), 2000 – 2012 50
Figure 15: Hospital Information Systems, Global, Company Share (%), 2007 51
Figure 16: Healthcare IT, India, Overall Revenue ($ mn), 2000 – 2012 52
Figure 17: Coronary Stent, US, Overall Revenue ($ mn), 2000 – 2007 54
Figure 18: Drug Eluting Stent, US, Overall Revenue ($ mn), 2007 – 2012 57
Figure 19: Drug Eluting Stent, US, Company Share (%), 2007 58
Figure 20: Hip Resurfacing, US, Company Share (%), October 2008 60
Figure 21: Hip Resurfacing, US, Overall Revenue ($ mn), 2006 – 2012 62
Figure 22: Home Healthcare Equipment, Global, Overall Revenue ($ mn), 2007-2012 63
Figure 23: Diabetes care devices, Global, Overall Revenue ($ mn), 2000 – 2012 65
Figure 24: Glucose Monitoring and Insulin Delivery devices, Global, Overall Revenue ($ mn), 2000-2012 66
Figure 25: Diabetes Care Devices, Global, Company Share (%), 2007 67
Figure 26: Digital Signal Processing Hearing Aids, Global, Overall Revenue ($ mn), 2000 - 2012 68
Figure 27: Digital Signal Processing Hearing Aids, Global, Company Share (%), 2007 69
Figure 28: Respiratory Devices , Global, Company Share (%), 2007 70
Figure 29: CPAP and Nebulizers, Global, Overall Revenue ($ mn), 2000 – 2012 71
Figure 30: Drug Delivery Devices, Global, Overall Revenue ($ mn), 2000 – 2012 72
Figure 31: Dry Powdered Inhalers, Global, Overall Revenue ($ mn), 2000 – 2012 73
Figure 32: Needle Free Injections, Global, Overall Revenue ($ mn), 2007-2012 74
Figure 33: Infusion Pumps, Global, Overall Revenue ($ mn), 2000 – 2012 76
Figure 34: In Vitro Diagnostics, Global, Overall Revenue ($ mn), 2007 – 2012 79
Figure 35: Spinal Surgery, Global, Overall Revenue ($ mn), 2007 – 2012 81
Figure 36: Spinal non-fusion, US, Overall Revenue ($ mn), 2007 – 2012 83
Figure 37: Aortic Stent Graft, US, Overall Revenue ($ mn), 2000-2012 84
Figure 38: Glucose Monitoring, US, Overall Revenue ($ mn), 2000 – 2012 87
Figure 39: Mammography equipment, Global, Companies, %, 2007 88
Figure 40: Full Field Digital Mammography, Global, Overall Revenue ($ mn), 2000 – 2012 90
Figure 41: Hospital Supplies, Global, Overall Revenue ($ mn), 2000 – 2012 92
Figure 42: Cardiovascular Prosthetic Devices, Global, Companies, %, 2007 94
Figure 43: Arthroscopy, US, Overall Revenue ($ mn), 2000 – 2012 95
Figure 44: Intra Ocular Lens , US, Overall Revenue ($ mn), 2000 – 2012 96
Figure 45: Soft Contact Lens, US, Overall Revenue ($ mn), 2000 – 2012 98
Figure 46: Share price trends of leading medical equipment pure-plays, 2008 100
Figure 47: Share price trends of leading medical equipment pure-plays, January, 2005 – October, 2008 101
Figure 48: Global Medical Equipment Deal Landscape, 2008 102
Figure 49: Macro-environment Risk Susceptibility, Leading Medical Equipment Companies 103
Figure 50: Boston Scientific Corporation, Share Price ($), Adj Close*, January 02, 2008 – October 31, 2008 105
Figure 51: Genentech, Share Price ($), Adj Close*, July 18, 2008 – October 31, 2008 106
Figure 52: The US National Health Expenditures, Providers, %, 2006 109
Figure 53: Medical Equipment Financial Deals, January 1, 2008 – November 5. 2008 116
Figure 54: Medical Equipment Financial Deals, by Market, January 1, 2008 – November 5. 2008 117
Figure 55: Medical Equipment Acquisitions, by Market, January 1, 2008 – November 5. 2008 119
Figure 56: Electrophysiology Market, Global, Company Share, %, 2007 121
Figure 57: Electrophysiology Market, Global, Overall Revenue ($mn), 2000-2012 122
Figure 58: Cardiovascular Surgery & Cardiac Assist Devices Market, Global, Overall Revenue ($mn), 2007-2012 123
Figure 59: Global Markets Direct Methodology 126